Revvity Board Declares Quarterly Dividend | RVTY Stock News

3 days ago

Revvity (RVTY, Financial) declares a $0.07 quarterly dividend per share.
Dividend payable on August 8, 2025, for shareholders as of July 18, 2025.
Revvity reported revenue of over $2.7 billion in 2024.

The Board of Directors of Revvity (RVTY) has announced a regular quarterly dividend of $0.07 per share of common stock. This dividend is scheduled for payment on August 8, 2025, to shareholders who are recorded as of the close of business on July 18, 2025.

Revvity is a leader in providing comprehensive health science solutions and services, focusing on translating multi-omics technologies, biomarker identification, and diagnostic innovations. With 11,000 employees worldwide, Revvity's revenue exceeded $2.7 billion in 2024, and it plays a significant role in the pharmaceutical, biotech, and diagnostic lab industries. Additionally, the company is listed on the S&P 500 index, serving a global customer base across more than 160 countries.

Revvity's recent developments include obtaining FDA approval for an advanced automated latent tuberculosis test and expanding its alliance with Genomics England to further newborn genomic sequencing research.

Also check out: (Free Trial)

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.